DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Arrowhead Research Corporation (ARWR)
« Back to company indexARWR Chatter Timeline
Stock Ticker for ARWR
Most Active Tweeters for ARWR
| User | Tweets |
|---|---|
| @battagliame30 | 39 |
| @BikeRieder | 19 |
| @truthtracer | 17 |
| @engrcat | 12 |
| @pt117cool | 8 |
Recent Tweets for ARWR
 |
@truthtracer No bold numerical predictions, but it’s a matter of time before the Locarnini $ARWR trumpeting really gains tractio… https://t.co/CTwYn8wazP March 21st 2019, 7:03pm |
|
@truthtracer @Dwyanosaurus I see what you see, couple of weeks now. But there really is substance here. $ARWR March 21st 2019, 6:03pm |
 |
@SauveRod @semodough Let RNAi have a chance at it, $ARWR and $ALNY come to mind.. March 21st 2019, 4:03pm |
 |
@newswithvalue $ARWR: Is Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) CEO Salary …: https://t.co/3H0l0GhzJs March 21st 2019, 2:03pm |
 |
@GaryR_1951 RT @BioBoyScout: $ARWR new US Patent Application published for "5'-Cyclo-Phosphonate Modified Nucleotides." Improved stability and potency… March 21st 2019, 2:03pm |
 |
@1111DLH61 Would like to see $ARWR break out of the top of the wedge but may take a bit more squeezing March 21st 2019, 12:03pm |
 |
@HatchingGains $ARWR Pulling back into rising moving averages and attempting to print a higher low. https://t.co/dm8DbRtStT March 21st 2019, 10:03am |
 |
@FlyOnTheWallHQ RT @FlyOnTheWallHQ: A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of New J… March 21st 2019, 8:03am |
 |
@BioBoyScout $ARWR new US Patent Application published for "5'-Cyclo-Phosphonate Modified Nucleotides." Improved stability and p… https://t.co/qderTOQeBu March 21st 2019, 7:03am |
 |
@UlmHi Neurotrope Inc. $ARWR Comparing side by side https://t.co/VeCjq1vJJO March 20th 2019, 11:03pm |
 |
@MarkC53916729 @RNAiAnalyst @CaesarBiotech Dr Given $ARWR spoke at Jefferies about the possibility that hitting #HBV weekly w/JNJ… https://t.co/xEWmS0uXNs March 20th 2019, 8:03pm |
 |
@thefinreviewer Agenus Inc. $ARWR Comparing side by side https://t.co/gPYikxBBcU March 20th 2019, 8:03pm |
|
@FlyOnTheWallHQ A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of N… https://t.co/EwyVjOWbVc March 20th 2019, 7:03pm |
 |
@battagliame30 RT @truthtracer: @battagliame30 ~To thine own self, be true. $ARWR made a “pivotal” leap. Reverberations of the ARO-AAT pivotal Phase 2-3 w… March 20th 2019, 7:03pm |
|
@battagliame30 @BikeRieder That’s because, “breakthroughs can happen,” especially at Arrowhead. $ARWR #AROAAT March 20th 2019, 5:03pm |
 |
@BikeRieder $ARWR It will not take 30 days to get approval from FDA for an in details discussed and prearranged AROAAT Phase II… https://t.co/XvoWZ4Mr5H March 20th 2019, 5:03pm |
 |
@_JessieJames100 RT @hedgiehedgerton: $SBPH short interest going out like the tide. (I remember when $ARWR short interest looked like this. It was in the Sp… March 20th 2019, 4:03pm |
 |
@hedgiehedgerton $SBPH short interest going out like the tide. (I remember when $ARWR short interest looked like this. It was in the… https://t.co/LSJpbLHq07 March 20th 2019, 3:03pm |
|
@MarkC53916729 @engrcat Only possible China tariff impact to $ARWR is after JNJ3989 FDA approved and very likely after ARO-AAT is… https://t.co/3OlaHzhLvo March 20th 2019, 1:03pm |
 |
@OlympiaReport Analysts Set Arrowhead Pharmaceuticals Inc $ARWR PT at $21.36 https://t.co/DC45x1uOAj March 20th 2019, 1:03pm |
 |
@dispatchtribune Arrowhead Pharmaceuticals Inc $ARWR Receives $21.36 Average Target Price from Brokerages https://t.co/ccUNSrOVIw March 20th 2019, 1:03pm |
|
@BikeRieder $ARWR In the past, there were some doubts on biotwitter and YMB about FDA not really “friendly” with RNAi companies… https://t.co/LUbyIcPvKS March 20th 2019, 10:03am |
 |
@StockTweetsHQ RT @StockTweetsHQ: A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of New Jo… March 20th 2019, 9:03am |
 |
@UnknownPatriot7 RT @BikeRieder: $ARWR FDA has changed a lot with S. Gottlieb in charge. This pivotal phase II/III AROAAT trial is based on data from health… March 19th 2019, 10:03pm |
 |
@BlogYomi Neon Therapeutics Inc. $ARWR https://t.co/dDiv6aBTAR March 19th 2019, 10:03pm |
|
@StockTweetsHQ A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of N… https://t.co/9U3sWoCEDu March 19th 2019, 8:03pm |
|
@battagliame30 @cranium88 @MarkC53916729 Not too sure what their (OppyFds) current percentage position of $ARWR is. March 19th 2019, 5:03pm |
|
@MarkC53916729 @engrcat I think most non traders realize that $ARWR has no intention to sell at this point, mgmt has stated repeat… https://t.co/UG7ZpVWbvI March 19th 2019, 12:03pm |
 |
@engrcat My theory on $ARWR selling off on good PR’s is that a significant base of holders only see it as a takeout target,… https://t.co/Br6y1FNcVs March 19th 2019, 11:03am |
|
@battagliame30 @truthtracer I’ve stated before more than once, $ARWR has some of the best PIs (Principal Investigators) from around the world. March 19th 2019, 4:03am |
|
@truthtracer @battagliame30 ~To thine own self, be true. $ARWR made a “pivotal” leap. Reverberations of the ARO-AAT pivotal Phas… https://t.co/giIdIZNSxI March 19th 2019, 3:03am |
|
@battagliame30 @truthtracer “If allowed,” in the context of being modest, not dubious. I’m so bullish on $ARWR now, you know that.… https://t.co/jkurtBWB1y March 19th 2019, 1:03am |
|
@battagliame30 @truthtracer I mean AROAAT and even AROHBV. $ARWR March 19th 2019, 1:03am |
|
@BlogYomi Comparing of Hoth Therapeutics Inc. $ARWR https://t.co/jNbEIcnIdP March 19th 2019, 12:03am |
|
@BikeRieder $ARWR Dear FDA, based on the new AROAAT trial design: lets do all future RNAi trials My @ArrowheadPharma Way… https://t.co/yO4B1WYyt5 March 18th 2019, 11:03pm |
|
@BikeRieder $ARWR FDA has changed a lot with S. Gottlieb in charge. This pivotal phase II/III AROAAT trial is based on data fro… https://t.co/kgQFf4GdeM March 18th 2019, 11:03pm |
 |
@VM1409 RT @RNA_Biotech: $ARWR IND for -- PIVOTAL -- Phase 2/3 Study of ARO-AAT https://t.co/QKPbzMODrF March 18th 2019, 10:03pm |
|
@battagliame30 @truthtracer I got it! Great point, and thanks for the clarity, all things good on $ARWR March 18th 2019, 10:03pm |
|
@battagliame30 @truthtracer “If allowed,” comments referring to future $ARWR programs following a similar AROAAT model. We’re on t… https://t.co/Oo0HA4CfQ9 March 18th 2019, 10:03pm |
 |
@cranium88 Maybe Baker bros is $ions buyer now that they’ve sold out of $arwr ? March 18th 2019, 9:03pm |
|
@battagliame30 @truthtracer I strongly AGREE! $ARWR March 18th 2019, 8:03pm |
|
@thefinreviewer aTyr Pharma Inc. $ARWR Comparing side by side https://t.co/4Z9ZVVtI4D March 18th 2019, 7:03pm |
 |
@Mcdivot06 @truthtracer @battagliame30 If $ARWR didn’t learn from their ARC filing problem, then there’s a learning disability… https://t.co/YjOaWp16LQ March 18th 2019, 7:03pm |
|
@OlympiaReport $44.63 Million in Sales Expected for Arrowhead Pharmaceuticals Inc $ARWR This Quarter https://t.co/CwrqZM4QbY March 18th 2019, 6:03pm |
 |
@WeekHerald Arrowhead Pharmaceuticals Inc $ARWR Expected to Post Quarterly Sales of $44.63 Million https://t.co/sIZ7KQ6owJ March 18th 2019, 6:03pm |
|
@truthtracer @battagliame30 Referencing the “if allowed” mention. Opinion here is $ARWR doesn’t file the IND until there’s a pre… https://t.co/x4rgdfpPki March 18th 2019, 6:03pm |
|
@battagliame30 @truthtracer $ARWR Phase 2/3 adaptive design process, my reference. March 18th 2019, 6:03pm |
|
@truthtracer @battagliame30 $ARWR has already laid the foundation of intelligently designed parallel trials neatly at the feet o… https://t.co/17LP9FRDMm March 18th 2019, 5:03pm |
|
@truthtracer @mhrob Agreed. $ARWR building something special here. Matter of time before diverse media forms turn their attentio… https://t.co/5Y04xMv9FG March 18th 2019, 5:03pm |
|
@battagliame30 @truthtracer AROAAT-PIVOTAL Phase 2/3 study creates a foundation for other $ARWR programs to follow suit, if allowe… https://t.co/SA8tPtyLss March 18th 2019, 5:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.